AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $535,078 | +4.9% | 7,656 | +7.9% | 0.00% | +100.0% |
Q2 2023 | $510,062 | +21.8% | 7,098 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $418,746 | -29.6% | 6,789 | -12.0% | 0.00% | -50.0% |
Q4 2022 | $595,058 | +100.4% | 7,715 | +15.7% | 0.00% | +100.0% |
Q3 2022 | $297,000 | +24.3% | 6,668 | +6.6% | 0.00% | 0.0% |
Q2 2022 | $239,000 | -36.8% | 6,253 | -31.4% | 0.00% | 0.0% |
Q1 2022 | $378,000 | -12.1% | 9,118 | -19.9% | 0.00% | 0.0% |
Q4 2021 | $430,000 | +12.3% | 11,383 | -1.9% | 0.00% | 0.0% |
Q3 2021 | $383,000 | -59.3% | 11,608 | -16.8% | 0.00% | -66.7% |
Q2 2021 | $942,000 | +32.3% | 13,958 | +11.0% | 0.00% | +50.0% |
Q1 2021 | $712,000 | -26.5% | 12,572 | +5.6% | 0.00% | -50.0% |
Q4 2020 | $969,000 | +44.6% | 11,900 | +26.6% | 0.00% | +33.3% |
Q3 2020 | $670,000 | -16.0% | 9,402 | -3.0% | 0.00% | -25.0% |
Q2 2020 | $798,000 | +114.5% | 9,693 | +53.2% | 0.00% | +33.3% |
Q1 2020 | $372,000 | -66.9% | 6,328 | -41.8% | 0.00% | -40.0% |
Q4 2019 | $1,124,000 | – | 10,873 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |